Table 5.
AA change | ΔEVDW ± SD | ΔEeel ± SD | ± SD | ± SD | −TΔS ± SD | ΔGbind ± SD | ΔΔGbind |
---|---|---|---|---|---|---|---|
Afatinib | |||||||
Wild type | −61.40 ± 0.10 | −48.15 ± 0.18 | 73.63 ± 0.27 | −4.98 ± 0.00 | −26.44 ± 0.04 | −10.82 ± 0.11 | 0.00 |
L858R | −57.30 ± 0.07 | −39.64 ± 0.11 | 63.08 ± 0.35 | −4.86 ± 0.01 | −25.08 ± 0.05 | −9.82 ± 0.15 | 1.00 |
T790M | −61.81 ± 0.12 | −51.89 ± 0.04 | 75.89 ± 0.24 | −4.89 ± 0.00 | −26.59 ± 0.04 | −12.52 ± 0.04 | -1.70 |
L858R/T790M | −56.20 ± 0.19 | −44.91 ± 0.51 | 67.44 ± 0.63 | −4.81 ± 0.01 | −25.08 ± 0.01 | −9.70 ± 0.09 | 1.12 |
G719S | −61.60 ± 0.07 | −49.44 ± 0.13 | 72.29 ± 0.17 | −5.08 ± 0.00 | −27.02 ± 0.01 | −13.41 ± 0.06 | -2.53 |
L858R/G719S | −59.91 ± 0.17 | −44.81 ± 0.42 | 69.70 ± 0.73 | −5.03 ± 0.01 | −26.18 ± 0.02 | −9.95 ± 0.42 | 0.87 |
D761Y | −59.70 ± 0.15 | −43.60 ± 0.32 | 68.53 ± 0.33 | −5.00 ± 0.01 | −25.79 ± 0.07 | −10.18 ± 0.16 | 0.64 |
L858R/D761Y | −60.82 ± 0.21 | −43.61 ± 0.62 | 68.08 ± 0.41 | −4.95 ± 0.01 | −26.34 ± 0.05 | −11.18 ± 0.29 | -0.36 |
L861Q | −57.05 ± 0.19 | −45.41 ± 0.19 | 68.56 ± 0.21 | −4.85 ± 0.01 | −25.25 ± 0.05 | −9.62 ± 0.02 | 1.20 |
L858R/L861Q | −57.84 ± 0.41 | −44.37 ± 0.22 | 69.58 ± 0.27 | −4.93 ± 0.00 | −25.50 ± 0.00 | −7.71 ± 0.31 | 3.11 |
Gefitinib | |||||||
Wild type | −55.40 ± 0.14 | −13.78 ± 0.18 | 40.40 ± 0.43 | −4.52 ± 0.01 | −24.05 ± 0.02 | −9.25 ± 0.36 | 0.00 |
L858R | −55.89 ± 0.24 | −13.48 ± 0.22 | 38.70 ± 0.04 | −4.62 ± 0.01 | −24.38 ± 0.07 | −10.92 ± 0.21 | -1.67 |
T790M | −57.62 ± 0.24 | −15.56 ± 0.49 | 41.91 ± 0.35 | −4.45 ± 0.01 | −24.84 ± 0.07 | −10.88 ± 0.05 | -1.63 |
L858R/T790M | −52.81 ± 0.29 | −11.59 ± 0.34 | 36.72 ± 0.28 | −4.28 ± 0.01 | −23.32 ± 0.03 | −8.64 ± 0.20 | 0.61 |
G719S | −54.02 ± 0.10 | −23.07 ± 0.18 | 50.34 ± 0.55 | −4.33 ± 0.01 | −23.75 ± 0.03 | −7.33 ± 0.51 | 1.92 |
L858R/G719S | −53.62 ± 0.41 | −12.49 ± 0.33 | 39.51 ± 0.18 | −4.40 ± 0.01 | −23.72 ± 0.08 | −7.29 ± 0.26 | 1.96 |
D761Y | −54.15 ± 0.13 | −15.11 ± 0.25 | 41.75 ± 0.34 | −4.57 ± 0.01 | −23.78 ± 0.03 | −8.30 ± 0.28 | 0.95 |
L858R/D761Y | −54.48 ± 0.31 | −17.72 ± 0.15 | 45.08 ± 0.60 | −4.39 ± 0.01 | −23.85 ± 0.08 | −7.66 ± 0.19 | 1.59 |
L861Q | −51.40 ± 0.22 | −17.36 ± 0.17 | 42.07 ± 0.41 | −4.31 ± 0.01 | −22.94 ± 0.06 | −8.06 ± 0.18 | 1.19 |
L858R/L861Q | −52.43 ± 0.04 | −13.57 ± 0.31 | 38.82 ± 0.43 | −4.23 ± 0.00 | −23.24 ± 0.05 | −8.18 ± 0.74 | 1.07 |
Note: All energy terms are in kcal/mol. The relative binding free energy of a mutant, ΔΔGbind, is calculated by subtracting the MM-PBSA binding free energy of the wild type from that of the mutant. The following is the detailed description of energy terms listed in the table. ΔEVDW: van der Waals energy. ΔEeel: electrostatic energy. : the polar part of the solvation free energy. : the nonpolar part of the solvation free energy. −TΔS: the entropic contribution to the binding free energy. ΔGbind, the binding free energy, which is the sum of the above individual energy terms. ΔΔGbind is the relative binding free energy compared to the wild type. SD: standard deviation.